Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
10%
Ph not_applicable
7
70%
Ph phase_2
2
20%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
2(20.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(5)
Terminated(2)
Other(3)

Detailed Status

Completed5
unknown3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (10.0%)
Phase 22 (20.0%)
N/A7 (70.0%)

Trials by Status

withdrawn220%
unknown330%
completed550%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10